In vitro permeation of platinum and rhodium through Caucasian skin

Toxicology in Vitro

Volumn 28, Issue 8, 2014, Pages 1396-1401

  Franken, A ^a   Eloff, F C ^a   Du Plessis, J ^a   Badenhorst, C J ^a   Jordaan, A ^a   Du Plessis, J L ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Caucasian skin; Franz diffusion cells; Platinum group metals (PGMs); Skin permeation; Skin sensitisation

Indexed keywords

PLATINUM; RHODIUM;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MASS SPECTROMETRY; SKIN PENETRATION; SKIN SENSITIZATION; SKINFOLD THICKNESS;

EID: 84906065648     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.07.007     Document Type: Article

References (37)

1. Barry B.W. Transdermal drug delivery. Aulton's Pharmaceutics the Design and Manufacture of Medicines 2007, 578. Elsevier Limited, Philadelphia, (ISBN 9780443101076). M.E. Aulton (Ed.).
2. Bedello P.G., Goitre M., Roncarlo G. Contact dermatitis to rhodium. Contact Dermatitis 1987, 17:111-112.
3. Bolm-Audorff U., Bienfait H.G., Burkhard J., Bury A.H., Merget R., Pressel G., Schultze-Werninghaus G. Prevalence of respiratory allergy in a platinum refinery. Int. Arch. Occup. Environ. Health 1992, 64:257-260.
4. Bos J.D., Meinardi M.M.H.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 2000, 9:165-169.
5. Box G.E.P., Cox D.R. An analysis of transformations. J. R. Stat. Soc. B. Met. 1964, 26(2):211-252.
6. Calverley A.E., Rees D., Dowdeswell R.J., Linnett P.J., Kielkowski D. Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup. Environ. Med. 1995, 52:661-666.
7. Chamber of Mines, 2012. Facts and figures 2012. Available at URL: http://www.bullion.org.za.
8. Cleare M.J., Hughes E.G., Jacoby B., Pepys J. Immediate (type I) allergenic responses to platinum compounds. Clin. Allergy. 1976, 6:183-195.
9. Cristaudo A., Sera F., Severino V., De Rocco M., Di Lella E., Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005, 60:159-164.
10. De La Cuadra J., Grau-Massanées M. Occupational contact dermatitis from rhodium and cobalt. Contact Dermatitis 1991, 25:182-184.
11. Díez-Sales O., Copoví A., Casabó V.G., Herráez M. A modelistic approach showing the importance of the stagnant aqueous layers in in vitro diffusion studies, and in vitro-in vivo correlations. Int. J. Pharm. 1991, 77:1-11.
12. Du Plessis J.L., Eloff F.C., Badenhorst C.J., Olivier J., Laubscher P.J., Van Aarde M.N., Franken A. Assessment of dermal exposure and skin condition of workers exposed to nickel at a South African base metal refinery. Ann. Occup. Hyg. 2010, 54(1):23-30.
13. Du Plessis, J.L., Eloff, F.C., Engelbrecht, S., Laubscher, P.J., Van Aarde, M.N., Franken, A., 2013. Dermal exposure and changes in skin barrier function of base metal refinery workers co-exposed to cobalt and nickel. Occ. Health. S.A., 19(1), pp. 6-12.
14. Fasano W.J., Hinderliter P.M. The Tinsley LCR Databridge Model 6401 and electrical impedance measurements to evaluate skin integrity in vitro. Toxicol. In Vitro 2004, 18:725-729.
15. Franz T.J. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64(3):190-195.
16. Goossens A., Cattaert N., Nemery B., Boey L., De Graef E. Occupational allergic contact dermatitis caused by rhodium solutions. Contact Dermatitis 2011, 64:158-161.
17. Guy R.H., Hadgraft J. Structure-activity correlations in percutaneous absorption. Percutaneous Absorption - Mechanisms, Methodology, Drug delivery 1989, 96-98. Marcel Dekker Inc., New York, (ISBN 0-8247-8036-1). R.L. Bronaugh, H.I. Maibach (Eds.).
18. Guy R.H., Hadgraft J. Principles of skin permeability relevant to chemical exposure. Dermal and Ocular Toxicology 1991, 224-225. CRC Press, Florida, (ISBN 0-8493-8811-2). first ed. D.W. Hobson (Ed.).
19. Hadgraft J., Wolff M. Physiochemical and pharmacokinetic parameters affecting percutaneous absorption. Dermal and Transdermal Drug Delivery 1993, 164-166. CRC Press, Germany, (ISBN 3-8047-1223-1). R. Gurny, A. Teubner (Eds.).
20. Hadgraft J., Green P.G., Wotton P.K. Facilitated percutaneous absorption of charged drugs. Percutaneous Absorption - Mechanisms, Methodology, Drug Delivery 1989, Marcel Dekker Inc., New York. second ed. R.L. Bronaugh, H.I. Maibach (Eds.).
21. Harrison S.M., Barry B.W., Dugar P.H. Effects of freezing on human skin permeability. J. Pharm. Pharmacol. 1984, 36(4):261-262.
22. Iavicoli I., Cufino V., Corbi M., Goracci M., Caredda E., Cittadini A., Bergamaschi A., Sgambato A. Rhodium and iridium salts inhibit proliferation and induce DNA damage in rat fibroblasts in vitro. Toxicol. In Vitro 2012, 26:963-969.
23. Kao J. In vitro assessment of dermal absorption. Dermal and Ocular Toxicology 1991, 281-282. CRC Press, Florida, (ISBN 0-8493-8811-2). first ed. D.W. Hobson (Ed.).
24. Kielhorn J., Melber C., Keller D., Mangelsdorf I. Palladium - a review of exposure and effects to human health. Int. J. Hyg. Environ. Health 2002, 205:417-432.
25. Kierstan K.T.E., Beezer A.E., Mitchell J.C., Hadgraft J., Raghavan S.L., Davis A.F. UV-spectrophotometry study of membrane transport processes with a novel diffusion cell. Int. J. Pharm. 2001, 229:87-94.
26. Kiilunen M., Aitio A. Platinum. Handbook on the Toxicology of Metals 2007, 777-778. Elsevier, London, (ISBN 978-0-12-369413-3). third ed. G.F. Nordberg, B.A. Fowler, M. Nordberg, L.T. Friberg (Eds.).
27. Knorr F., Lademann J., Patzelt A., Sterry W., Blume-Peytavi U., Vogt A. Follicular transport route - research progress and future perspectives. Eur. J. Pharm. Biopharm. 2009, 71:173-180.
28. Larese Filon F., Gianpietro A., Venier M., Maina G., Renzi N. In vitro percutaneous absorption of metal compounds. Toxicol. Lett. 2007, 170:49-56.
29. Larese Filon F., D'Agostin F., Crosera M., Adami G., Bovenzi M., Maina G. In vitro absorption of metal powders through intact and damaged human skin. Toxicol. In Vitro 2009, 23:574-579.
30. Linnett P.J., Hughes E.G. 20 Years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: the importance of chemical speciation. Occup. Environ. Med. 1999, 56:191-196.
31. Maynard A.D., Northage C., Hemingway M., Bradley S.D. Measurement of short-term exposure to airborne soluble platinum in the platinum industry. Ann. Occup. Hyg. 1997, 41(1):77-94.
32. McDougal J.N., Boeniger M.F. Methods for assessing risks of dermal exposures in the workplace. Crit. Rev. Toxicol. 2002, 32(4):291-327.
33. Merget R., Kulzer R., Dierkes-Globisch A., Breitstadt R., Gebler A., Kniffka A., Artelt S., Koenig H., Alt F., Vormber R., Baur X., Schutlze-Werninghaus G. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: Conclusions from a 5-year prospective cohort study. J. Allergy Clin. Immunol. 2000, 105(2):364-370.
34. National Institute for Occupational Safety and Health (NIOSH), 2013. NIOSH pocket guide to chemical hazards. Available at. http://www.cdc.gov/niosh/npg/default.html.
35. Ravindra K., Bencs L., Van Grieken R. Platinum group elements in the environment and their health risk. Sci. Total Environ. 2004, 318:1-43.
36. Santucci B., Valenzano C., De Rocco M., Cristaudo A. Platinum in the environment: frequency of reactions to platinum-group elements in patients with dermatitis and urticaria. Contact Dermatitis 2000, 43:333-338.
37. Smith K.L. Penetrant Characteristics Influence in Skin Absorption 1990, 27. CRC Press, Florida, (ISBN 0-8493-4651-7). B.W. Kemppainen, W.G. Reifenrath (Eds.).